The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese

Table 2

Adjusted odds ratios and 95% confidence intervals for specific types of cancer associated with type 2 diabetes.

Site-specific cancer	Patients with type 2 diabetes		Subjects without diabetes		Adjusted odds ratio		𝑃 value
	(𝑛=61777)		(𝑛=677378)		(95% CI)
	Cases	%	Cases	%
Breast	665	2.20	4042	1.16	1.111	(1.018–1.212)	0.018
Prostate	587	1.86	2223	0.68	1.137	(1.036–1.249)	0.007
Colon	1739	1.98	7219	1.07	1.206	(1.142–1.274)	<0.001
Lung	1226	2.81	4281	0.63	1.296	(1.214–1.384)	<0.001
Liver	1528	2.47	5558	0.82	1.582	(1.491–1.680)	<0.001
Stomach	523	0.85	2700	0.40	0.920	(0.836–1.012)	0.088
Pancreas	286	0.46	731	0.11	2.038	(1.768–2.349)	<0.001

Subjects without diabetes as reference and adjustment for sex and age.